Part 2/10:
Contrary to popular belief, GLP-1 drugs are not a new invention. They have been utilized for decades in managing type 2 diabetes by helping regulate blood sugar levels. When trials were conducted on their weight loss abilities, the results were promising—participants generally lost significant weight when combined with a healthy diet and exercise. Semaglutide, the primary ingredient in OIC, has demonstrated an average weight loss of about 15% in clinical trials, whereas newer drugs like Tepati have shown even higher results.